CD4 and neoplasm: Finally, in tumor immunology, indirect presentation of tumor‐associated antigens by professional APC has been shown to induce beneficial immune responses in which MHC class II‐negative tumors can be rejected in a CD4 T‐cell dependent fashion 10, 11, 12.